17 related news articles for Gastrointestinal Infection and Inflammation

Through a greater understanding of H. pylori infection, we are identifying molecular targets that can be used for better diagnosis, new therapies and preventative treatments, such as vaccines, against the diseases caused by this bacterium.…  Read more

Congratulations to the recipients of the 2024 Hudson Institute Harold Mitchell Fellowships.

The Travel Fellowships are provided by the Harold Mitchell Foundation, giving young scientists much-needed opportunities to travel and expand their research horizons.…  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.…  Read more

Despite encountering more than her share of health challenges, 92-year-old Delva Walker has the most positive outlook you are ever likely to encounter.…  Read more

As in so many cases, a tragic bereavement – the death of her husband from stomach cancer – was the catalyst for Janine’s decision to donate to medical research.…  Read more

Six of the best early career researchers have been chosen to take part in the Hudson Institute 2023 Emerging Leaders Program. …  Read more

The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.…  Read more

A squadron of high school scientists has spent a week at Hudson Institute exploring a future in STEM. Year 10 students from secondary schools throughout Melbourne’s south-east spent a week at the Clayton campus, each matched with a female mentor, being shown the ropes of a career in medical research.…  Read more

A bacterium present in half the world’s population, Helicobacter pylori  is the target of new research aiming to develop a vaccine against stomach cancer.  …  Read more

Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants. These grants support innovative and creative research and build on Australia’s strong skills and international reputation in advanced health and medical research.…  Read more

Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.…  Read more

Researchers have identified a protein in immune cells that may play a role in thwarting a type of stomach cancer, paving the way for possible prevention therapies.…  Read more

Hudson Institute is delighted to announce the success of our researchers in the new NHMRC Investigator Grant round.…  Read more

More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.…  Read more

Pioneering Australian clinicians, Barry Marshall and Robin Warren first reported in 1982 that the stomach bacterium, Helicobacter pylori (H.plylori) causes gastritis and is a major risk factor in peptic ulcer disease and stomach cancer. Marshall and Warren were awarded the Nobel Prize in Physiology or Medicine in 2005 for their discovery, which has resulted in…  Read more

Why does a common bug, Helicobacter pylori, which is present in the stomachs of around half the world’s population, drive stomach cancer in some people? Associate Professor Richard Ferrero will establish how this seemingly innocuous bacterium drives growth of a specific type of stomach tumour, thanks to generous funding from the US Department of Defense.…  Read more